Stay updated with breaking news from Myopia Progression. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Wyniki badania LAMP
Myopia, or nearsightedness, is at an all-time high among children in the US. Globally, half the population is expected to be nearsighted by 2050.
Two studies presented at AAO demonstrate that low dose atropine is associated with slowing myopia progression, but another study finds that this is not true. Thus, there are mixed results on this relationship.
Essilor® encourages parents to take their children to the optometrist as a preventive measureMONTREAL, Aug. 08, 2023 (GLOBE NEWSWIRE) -- A recent survey conducted by Essilor®, part of EssilorLuxottica a leading global eyecare and eyewear provider1, reveals that children’s eye health and vision are often overlooked by parents amidst the many other concerns they face. The survey, which sampled responses from 1,019 Canadian parents, reveals that 1 in 6 Quebec parents have never brought their childr
Clinical trial suggests low-dose atropine is an effective myopia treatment. The results of a new clinical trial suggest that the first drug therapy to slow the progression of nearsightedness in kids could be on the horizon. The three-year study found that a daily drop in each eye of a low dose o